RYOIX - Rydex Biotechnology Inv

Nasdaq - Nasdaq Delayed Price. Currency in USD
93.94
-0.13 (-0.14%)
At close: 4:55PM EDT
Stock chart is not supported by your current browser
Previous Close94.07
YTD Return31.27%
Expense Ratio (net)1.37%
CategoryHealth
Morningstar Rating★★★
Morningstar Risk Rating★★★★★
Last Cap Gain0.00
Net Assets403.57M
Beta (3y)1.38
Yield0.00%
Holdings Turnover207.00%
Last Dividend0.00
Inception DateApr 1, 1998
Average for CategoryN/A
  • We're sorry we weren't able to find anything about this topic.